Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomáš Hanke

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Current Opinion in HIV and AIDS|September 30, 2022
New vector and vaccine platforms: mRNA, DNA, viral vectorsTomáš Hanke
Expert Opinion on Biological Therapy|February 5, 2014
Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccinesTomáš Hanke
Expert Review of Vaccines|October 16, 2019
Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trialsTomáš Hanke
Vaccines|January 24, 2025
Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 VaccineJoseph Bruton, Tomáš Hanke
The Journal of General Virology|December 16, 2006
Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell inductionTomáš Hanke, Andrew J McMichael, Lucy Dorrell
Clinical and Vaccine Immunology : CVI|September 19, 2014
Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c miceBeatrice Ondondo, Sultan Abdul-Jawad, Anne Bridgeman, et al.
Vaccines|July 29, 2023
Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNADavid A Matthews, Rachel Milligan, Edmund G Wee, et al.
Vaccine|July 9, 2013
Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c miceBeatrice Ondondo, Caroline Brennan, Alfredo Nicosia, et al.
The Journal of General Virology|December 26, 2001
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaquesEdmund G-T Wee, Sandip Patel, Andrew J McMichael, et al.
Journal of Immunological Methods|May 20, 2016
A statistical approach to determining responses to individual peptides from pooled-peptide ELISpot dataPeter Ström, Nathalie Støer, Nicola Borthwick, et al.
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Current Opinion in HIV and AIDS|September 30, 2022
New vector and vaccine platforms: mRNA, DNA, viral vectorsTomáš Hanke
Expert Opinion on Biological Therapy|February 5, 2014
Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccinesTomáš Hanke
Expert Review of Vaccines|October 16, 2019
Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trialsTomáš Hanke
Vaccines|January 24, 2025
Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 VaccineJoseph Bruton, Tomáš Hanke
The Journal of General Virology|December 16, 2006
Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell inductionTomáš Hanke, Andrew J McMichael, Lucy Dorrell
Clinical and Vaccine Immunology : CVI|September 19, 2014
Characterization of T-cell responses to conserved regions of the HIV-1 proteome in BALB/c miceBeatrice Ondondo, Sultan Abdul-Jawad, Anne Bridgeman, et al.
Vaccines|July 29, 2023
Adenovirus Transcriptome in Human Cells Infected with ChAdOx1-Vectored Candidate HIV-1 Vaccine Is Dominated by High Levels of Correctly Spliced HIVconsv1&62 Transgene RNADavid A Matthews, Rachel Milligan, Edmund G Wee, et al.
Vaccine|July 9, 2013
Absence of systemic toxicity changes following intramuscular administration of novel pSG2.HIVconsv DNA, ChAdV63.HIVconsv and MVA.HIVconsv vaccines to BALB/c miceBeatrice Ondondo, Caroline Brennan, Alfredo Nicosia, et al.
The Journal of General Virology|December 26, 2001
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaquesEdmund G-T Wee, Sandip Patel, Andrew J McMichael, et al.
Journal of Immunological Methods|May 20, 2016
A statistical approach to determining responses to individual peptides from pooled-peptide ELISpot dataPeter Ström, Nathalie Støer, Nicola Borthwick, et al.
Pageof 9